BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30251430)

  • 1. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
    Dunkoksung W; Vardhanabhuti N; Jianmongkol S
    J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
    Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
    Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
    Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
    Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of Colorectal HIV Transmission.
    Swedrowska M; Jamshidi S; Kumar A; Kelly C; Rahman KM; Forbes B
    Mol Pharm; 2017 Aug; 14(8):2660-2669. PubMed ID: 28648081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible Regulation of P-Glycoprotein Function by Adrenergic Agonists II: Study with Isolated Rat Jejunal Sheets and Caco-2 Cell monolayers.
    Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K
    J Pharm Sci; 2024 May; 113(5):1209-1219. PubMed ID: 37984697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and better protocols for a short-term Caco-2 cell culture system.
    Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
    J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
    Bourdet DL; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.
    Zhao A; Mu H; Yao W; Chang X; Li W; Wang R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):491-498. PubMed ID: 37385611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
    Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
    Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
    Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
    Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits.
    Kajikawa T; Mishima HK; Murakami T; Takano M
    Curr Eye Res; 1999 Mar; 18(3):240-6. PubMed ID: 10342379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells.
    Sukhaphirom N; Vardhanabhuti N; Chirdchupunseree H; Pramyothin P; Jianmongkol S
    J Pharm Pharmacol; 2013 Feb; 65(2):292-9. PubMed ID: 23278697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates.
    Ozgür B; Saaby L; Langthaler K; Brodin B
    Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.